Sign In
Buy DBVT
$13.63
-0.230 (-1.66%)
At Close: Jul 24, 2026
DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
04:30pm, Monday, 04'th Mar 2024
Montrouge, France, March 4, 2024 DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stoc
DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
04:30pm, Tuesday, 20'th Feb 2024
Montrouge, France, February 20 2024 DBV Technologies to Participate in Upcoming AAAAI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 –NASDAQ: DBVT), a clinical-stage biopharmac
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
04:30pm, Tuesday, 16'th Jan 2024
AMF Regulated Information Montrouge, France, January 16, 2024 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasda
Top 5 Health Care Stocks That Could Blast Off In December - DBV Technologies (NASDAQ:DBVT), Cigna Group (NYSE:CI)
10:47am, Friday, 01'st Dec 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Down -25.23% in 4 Weeks, Here's Why You Should You Buy the Dip in DBV Technologies S.A. (DBVT)
11:19am, Monday, 27'th Nov 2023
DBV Technologies S.A. (DBVT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it.
Montrouge, France, November 9, 2023 DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers Viaskin Peanut sh
DBV Technologies to Present New Data at ACAAI 2023
04:30pm, Thursday, 02'nd Nov 2023
Montrouge, France, November 2, 2023 DBV Technologies to Present New Data at ACAAI 2023 New data to include late-breaking abstract detailing interim 12-month results from the ongoing Phase 3 open-label
DBV Technologies S.A. (DBVT) Q3 2023 Earnings Call Transcript
09:57pm, Tuesday, 31'st Oct 2023
DBV Technologies S.A. (NASDAQ:DBVT ) Q3 2023 Earnings Conference Call October 31, 2023 5:00 PM ET Company Participants Katie Matthews - Head of Investor Relations Daniel Tassé - Chief Executive Offic
Montrouge, France, October 31, 2023 DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results DBV ha
DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
04:30pm, Friday, 27'th Oct 2023
Montrouge, France, October 27, 2023 DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market:
DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
02:00am, Monday, 16'th Oct 2023
Montrouge, France, October 16, 2023 DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Marke
DBV Technologies to Participate in Upcoming Investor Conference
04:30pm, Tuesday, 05'th Sep 2023
Montrouge, France, September 5, 2023 D BV Technologies to Participate in Upcoming Investor Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-
DBV Technologies S.A. (DBVT) Q2 2023 Earnings Call Transcript
08:02pm, Monday, 31'st Jul 2023
DBV Technologies S.A. (NASDAQ:DBVT ) Q2 2023 Earnings Call July 31, 2023 5:00 PM ET Company Participants Katie Matthews - Head of Investor Relations Daniel Tassé - Chief Executive Officer Sébastien
GlobeNewswire window.initGradientEffect = function () { } document.addEventListener('DOMContentLoaded', function () { const extendedTableZoomElements = document.querySelectorAll('.extended-table-zoom'
DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update
04:30pm, Tuesday, 25'th Jul 2023
Montrouge, France, July 25, 2023 DBV Technologies to Report First Half 202 3 Financial Results and Provide a Corporate Update DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Ma
